 |
|
Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study
Eileen L. Yoon, Sang Bong Ahn, Dae Won Jun, Yong Kyun Cho, Do Seon Song, Jae Yoon Jeong, Hee Yeon Kim, Young Kul Jung, Myeong Jun Song, Sung Eun Kim, Hyoung Su Kim, Soung Won Jeong, Sang Gyune Kim, Tae Hee Lee
Korean J Intern Med. 2022;37(4):757-767. Published online 2022 May 6 DOI: https://doi.org/10.3904/kjim.2021.338
|
|
Citations to this article as recorded by
 Factors Affecting and Promoting Health-related Quality of Life in Patients With Liver Cirrhosis: An Underestimated Domain in Patient Care
Siddheesh Rajpurohit, Balaji Musunuri, Pooja B. Mohan, Ganesh Bhat, Shiran Shetty
Journal of Clinical and Experimental Hepatology.2024; 14(1): 101264. CrossRef Clinical Outcome Assessments in Encephalitis
Juliette Brenner, Sammy H.C. Olijslagers, Yvette S. Crijnen, Juna M. de Vries, Melissa R. Mandarakas, Maarten J. Titulaer
Neurology Neuroimmunology & Neuroinflammation.2024;[Epub] CrossRef L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wenbo Wang, Da Pan, Qi Liu, Xiangjun Chen, Shaokang Wang
Nutrients.2024; 16(8): 1232. CrossRef The social and psychological impact of hepatic encephalopathy
Michael Sørensen, Mette Munk Lauridsen, Sara Montagnese
Metabolic Brain Disease.2024; 39(6): 1227. CrossRef Effects of l‐carnitine on frailty status in patients with liver cirrhosis: A randomized‐controlled trial
Nasrin Motazedian, Anita Ashari, Niloofar Dehdari Ebrahimi, Mehrab Sayadi, Sarina Pourjafar, Nazanin Motazedian, Vahid Khademi, Alireza Shamsaeefar, Ahad Eshraghian
Health Science Reports.2024;[Epub] CrossRef
|